Aflac Incorporated (NYSE:AFL) Shares Acquired by Shelton Capital Management

Shelton Capital Management raised its stake in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 126.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 125,501 shares of the financial services provider's stock after buying an additional 70,001 shares during the period. Shelton Capital Management's holdings in Aflac were worth $12,982,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the stock. Private Trust Co. NA boosted its stake in shares of Aflac by 1.3% during the 4th quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider's stock worth $791,000 after acquiring an additional 99 shares in the last quarter. Phillips Wealth Planners LLC lifted its position in shares of Aflac by 1.5% during the 4th quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider's stock valued at $662,000 after buying an additional 100 shares in the last quarter. Raleigh Capital Management Inc. grew its stake in Aflac by 23.2% in the 4th quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider's stock valued at $55,000 after acquiring an additional 100 shares during the period. TKG Advisors LLC increased its holdings in Aflac by 0.5% in the 4th quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider's stock worth $2,230,000 after acquiring an additional 103 shares in the last quarter. Finally, Robertson Stephens Wealth Management LLC raised its position in Aflac by 1.6% during the fourth quarter. Robertson Stephens Wealth Management LLC now owns 6,960 shares of the financial services provider's stock worth $720,000 after acquiring an additional 107 shares during the period. Hedge funds and other institutional investors own 67.44% of the company's stock.

Remove Ads

Insider Transactions at Aflac

In related news, Director Charles D. Lake II sold 29,802 shares of the firm's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the transaction, the director now owns 49,962 shares in the company, valued at $5,360,422.98. This trade represents a 37.36 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Joseph L. Moskowitz sold 1,000 shares of the business's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the sale, the director now owns 25,393 shares of the company's stock, valued at approximately $2,733,048.59. This represents a 3.79 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company's stock.

Aflac Stock Up 2.1 %

Shares of NYSE AFL traded up $2.16 during midday trading on Friday, hitting $106.84. The company's stock had a trading volume of 2,297,504 shares, compared to its average volume of 2,146,689. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. The firm has a market capitalization of $58.31 billion, a price-to-earnings ratio of 11.13, a price-to-earnings-growth ratio of 3.24 and a beta of 0.81. The business's fifty day simple moving average is $106.34 and its two-hundred day simple moving average is $107.41. Aflac Incorporated has a 1 year low of $79.69 and a 1 year high of $115.50.

Aflac (NYSE:AFL - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. On average, equities analysts predict that Aflac Incorporated will post 6.88 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the stock. JPMorgan Chase & Co. boosted their target price on shares of Aflac from $94.00 to $96.00 and gave the stock a "neutral" rating in a research note on Wednesday, April 2nd. Keefe, Bruyette & Woods decreased their price target on shares of Aflac from $107.00 to $104.00 and set a "market perform" rating on the stock in a research note on Wednesday, February 12th. Barclays dropped their price objective on shares of Aflac from $98.00 to $95.00 and set an "underweight" rating for the company in a research note on Friday, February 7th. Wells Fargo & Company decreased their target price on shares of Aflac from $104.00 to $102.00 and set an "equal weight" rating on the stock in a research note on Wednesday, February 19th. Finally, BMO Capital Markets initiated coverage on Aflac in a research report on Thursday, January 23rd. They set a "market perform" rating and a $111.00 price objective on the stock. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $103.93.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.